Jean-Guillaume Lafay

Jean-Guillaume Lafay has extensive work experience in the biotechnology industry. In 2018, they co-founded Mablink Bioscience and served as the Chief Executive Officer. In 2020, they founded Norfoalk S.A.S and held the position of Chief Executive Officer. In 2022, Jean-Guillaume Lafay co-founded Allogenica and served as the Chairman. Additionally, in the same year, they co-founded Kairos Discovery. Furthermore, in 2023, they co-founded AIS BIOTECH.

Jean-Guillaume Lafay has a diverse education history in chemistry, biochemistry, and molecular biology. Jean-Guillaume obtained a Master 2 degree in Organic Synthesis and Chemistry of Bioactive Molecules from Université Claude Bernard Lyon 1 in 2008. Before that, they completed a Bachelor's degree in Biochemistry and Molecular Biology (Licence de Biochimie) from the same institution in 1999. In 1998, they also completed a Deug degree in Biology, focusing on Biochemistry and Molecular Biology.

Jean-Guillaume Lafay has also pursued additional certifications to enhance their skillset. In 2019, they obtained a certification in Innovation Management from emlyon business school. Furthermore, in 2022, they acquired a certification in Effective International Communication from York Associates.